- Home
- CSPI vs PROK Comparison
CSPI vs PROK Comparison
Compare CSPI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSPI
- PROK
- Stock Information
- Founded
- CSPI 1968
- PROK 2015
- Country
- CSPI United States
- PROK United States
- Employees
- CSPI N/A
- PROK N/A
- Industry
- CSPI EDP Services
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSPI Technology
- PROK Health Care
- Exchange
- CSPI Nasdaq
- PROK Nasdaq
- Market Cap
- CSPI 174.4M
- PROK 186.8M
- IPO Year
- CSPI 1987
- PROK N/A
- Fundamental
- Price
- CSPI $16.26
- PROK $1.05
- Analyst Decision
- CSPI
- PROK Buy
- Analyst Count
- CSPI 0
- PROK 5
- Target Price
- CSPI N/A
- PROK $4.50
- AVG Volume (30 Days)
- CSPI 43.2K
- PROK 546.9K
- Earning Date
- CSPI 02-10-2025
- PROK 03-21-2025
- Dividend Yield
- CSPI 0.74%
- PROK N/A
- EPS Growth
- CSPI N/A
- PROK N/A
- EPS
- CSPI 0.02
- PROK N/A
- Revenue
- CSPI $55,514,000.00
- PROK N/A
- Revenue This Year
- CSPI N/A
- PROK N/A
- Revenue Next Year
- CSPI N/A
- PROK N/A
- P/E Ratio
- CSPI $868.41
- PROK N/A
- Revenue Growth
- CSPI N/A
- PROK N/A
- 52 Week Low
- CSPI $10.76
- PROK $0.98
- 52 Week High
- CSPI $24.44
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- CSPI 45.15
- PROK 23.63
- Support Level
- CSPI $15.14
- PROK $0.98
- Resistance Level
- CSPI $16.90
- PROK $1.32
- Average True Range (ATR)
- CSPI 1.09
- PROK 0.11
- MACD
- CSPI -0.23
- PROK -0.04
- Stochastic Oscillator
- CSPI 23.38
- PROK 10.61
About CSPI CSP Inc.
CSP Inc along with its subsidiaries develops and markets IT integration solutions, security products, managed IT services, cloud services, purpose-built network adapters, and high-performance cluster computer systems. The firm operates in two segments namely Technology Solutions, where the company focus on value-added reseller integrated solutions including third-party hardware, software, and technical computer-related consulting, and High-Performance Products segments, where the company design, manufacture and deliver products and services to customers that require specialized cyber security services, networking and signal processing. It generates a majority of its revenue from the Technology Solutions segment. Geographically, the company generates its maximum revenue from the Americas.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.